title: Ranolazine-induced Repolarization Changes: A Case Report.
authors: Department of Medicine, Jacobi Medical Center, Bronx, NY.
authors: Anand
authors: A
authors: Kumthekar
authors: Department of Medicine, Jacobi Medical Center, Bronx, NY.
authors: Francesca
authors: F
authors: Cossarini
authors: Department of Medicine, Jacobi Medical Center, Bronx, NY.
authors: Julia C
authors: JC
authors: Shih
authors: Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
authors: Cynthia C
authors: CC
authors: Taub
authors: Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY. Electronic address: dmassera@montefiore.org.
authors: Daniele
authors: D
authors: Massera
mesh_terms: D000083:Acetanilides / Q000009:adverse effects* / Q000627:therapeutic use; D000200:Action Potentials / Q000187:drug effects; D002637:Chest Pain / Q000175:diagnosis / Q000188:drug therapy; D017023:Coronary Angiography / Q000379:methods; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000628:therapy; D004562:Electrocardiography / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D000069458:Ranolazine; D018570:Risk Assessment; D026941:Sodium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D015607:Stents; D054549:Takotsubo Cardiomyopathy / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000083:Acetanilides; D010879:Piperazines; D026941:Sodium Channel Blockers; D000069458:Ranolazine